Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Health Catalyst, Inc. Director's Dealing 2019

Jul 30, 2019

33681_dirs_2019-07-29_64d15531-40ca-44ea-aa76-a2ba7eb13689.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-29

Reporting Person: KANE JOHN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-29 Common Stock C 23586 Acquired 80877 Direct
2019-07-29 Common Stock C 589 Acquired 81466 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-07-29 Series E Preferred Stock $ C 23586 Disposed Common Stock (23586.0) Direct
2019-07-29 Series F Preferred Stock $ C 589 Disposed Common Stock (589.0) Direct

Footnotes

F1: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2: Each share of Series F Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.